USA Gastrointestinal GI Stents Market Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

USA GI stents market grows with rising GI cancers, lifestyle disorders, and minimally invasive interventions.

Region:North America

Author(s):Shubham

Product Code:KRAD1834

Pages:100

Published On:December 2025

About the Report

Base Year 2024

USA Gastrointestinal GI Stents Market Overview

  • The USA Gastrointestinal GI Stents Market is valued at USD 0.6 billion, based on a five?year historical analysis. Growth is driven by the rising prevalence of gastrointestinal cancers and lifestyle-related digestive disorders alongside increased healthcare expenditure and preference for minimally invasive endoscopic interventions. Advances such as drug-eluting, biodegradable and anti-migration stent designs further propel adoption, supported by improved clinical outcomes and procedural efficiency.
  • Key players in this market include Boston Scientific, Cook Medical, Becton Dickinson, Taewoong Medical, Olympus and Merit Medical, which drive innovation through durable R&D pipelines and strategic expansion. Boston Scientific’s leadership is underscored by its WallFlex and AXIOS product lineup, while Cook Medical’s strength lies in minimally invasive designs, and other players contribute through visualization-integrated systems and regional manufacturing capabilities.
  • In 2024, the U.S. Food and Drug Administration announced specific guidance for metal expandable biliary stents under the 510(k) pathway, detailing performance standards for safety and efficacy in biliary applications—pivotal for GI stent approvals and market entry.
USA Gastrointestinal GI Stents Market Size

USA Gastrointestinal GI Stents Market Segmentation

By Type:The market is segmented into various types of stents, including self-expanding metal stents, plastic stents, covered stents, uncovered stents, and others. Among these, self-expanding metal stents dominate the market due to their superior flexibility and ability to adapt to the anatomy of the gastrointestinal tract, making them a preferred choice for many clinicians. The increasing adoption of these stents is also driven by advancements in design and materials, enhancing patient outcomes.

USA Gastrointestinal GI Stents Market segmentation by Type.

By End-User:The end-user segmentation includes hospitals, ambulatory surgical centers, specialty clinics, and others. Hospitals are the leading end-users, primarily due to their comprehensive facilities and access to advanced medical technologies. The increasing number of surgical procedures performed in hospitals, coupled with the growing patient population requiring gastrointestinal interventions, further solidifies their dominance in the market.

USA Gastrointestinal GI Stents Market segmentation by End-User.

USA Gastrointestinal GI Stents Market Competitive Landscape

The USA Gastrointestinal GI Stents Market is characterized by a dynamic mix of regional and international players. Leading participants such as Boston Scientific Corporation, Medtronic plc, Cook Medical, Abbott Laboratories, B. Braun Melsungen AG, Olympus Corporation, ConMed Corporation, Merit Medical Systems, Inc., EndoChoice, Inc., Stryker Corporation, C. R. Bard, Inc., Halyard Health, Inc., Ethicon, Inc., Terumo Corporation, Medline Industries, Inc. contribute to innovation, geographic expansion, and service delivery in this space.

Boston Scientific Corporation

1979

Natick, Massachusetts, USA

Medtronic plc

1949

Dublin, Ireland

Cook Medical

1963

Bloomington, Indiana, USA

Abbott Laboratories

1888

Abbott Park, Illinois, USA

B. Braun Melsungen AG

1839

Melsungen, Germany

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Product Innovation Rate

Distribution Efficiency

USA Gastrointestinal GI Stents Market Industry Analysis

Growth Drivers

  • Annual ERCP Procedures in the U.S.:Over 650,000 ERCP (endoscopic retrograde cholangiopancreatography) procedures are performed annually in the U.S. as of 2022. This high procedural volume directly supports the demand for gastrointestinal stents, particularly biliary stents. The increasing number of procedures correlates with a growing patient population suffering from gastrointestinal diseases, thereby driving the market for GI stents significantly ((https://www.fortunebusinessinsights.com/gastrointestinal-stent-market-114932?utm_source=openai)).
  • North America Market Value (2024):The North American GI stents market was valued at USD 245.0 million in the future. This substantial market value reinforces the U.S. leadership in the GI stents sector, driven by advanced healthcare infrastructure and high adoption rates of innovative stent technologies. The robust healthcare system facilitates the availability and accessibility of GI stents, further propelling market growth ((https://www.fortunebusinessinsights.com/gastrointestinal-stent-market-114932?utm_source=openai)).
  • U.S. Upper GI Stent Market Value (2024):The U.S. upper GI stent market is projected to reach USD 300 million in the future. This significant portion of the overall GI stents market highlights the focus on upper gastrointestinal interventions, which are increasingly performed due to rising incidences of related diseases. The demand for effective treatment options in this segment is expected to drive further innovations and market expansion ((https://www.linkedin.com/pulse/united-states-upper-gastrointestinal-stent-market-rkhbe/?utm_source=openai)).

Market Challenges

  • High Cost of Stents per Unit:The price range for GI stents varies between USD 800 and USD 2,500 per unit. This elevated cost presents a significant barrier to broader adoption, particularly in cost-sensitive healthcare settings. The financial burden associated with purchasing stents can deter healthcare providers from utilizing these devices, thereby limiting market penetration and growth opportunities ((https://www.datamintelligence.com/research-report/gastrointestinal-stents-market?utm_source=openai)).
  • High Procedure Cost:The cost of endoscopic stent placement procedures ranges from USD 3,000 to USD 10,000. These significant expenses, combined with variable reimbursement policies, create challenges for patients and healthcare providers alike. The high costs can limit access to necessary treatments, thereby impacting the overall growth of the GI stents market in the U.S. ((https://www.datamintelligence.com/research-report/gastrointestinal-stents-market?utm_source=openai)).

USA Gastrointestinal GI Stents Market Future Outlook

The future of the USA gastrointestinal GI stents market appears promising, driven by technological advancements and increasing healthcare accessibility. The adoption of smart and biodegradable stents is expected to enhance patient outcomes, while the expansion of ambulatory surgical centers (ASCs) will facilitate quicker access to GI stenting procedures. As the healthcare landscape evolves, these trends will likely foster innovation and improve the overall efficiency of gastrointestinal treatments, positioning the market for sustained growth in the coming years.

Market Opportunities

  • ASC-Focused Procurement:The growth of ambulatory surgical centers (6,308 in the future) presents a unique opportunity for targeted procurement strategies. Manufacturers can tailor their product offerings to meet the specific needs of ASCs, where the adoption of advanced stents is on the rise, thereby enhancing market penetration and revenue potential ((https://www.fortunebusinessinsights.com/gastrointestinal-stent-market-114932?utm_source=openai)).
  • North America Leadership:North America, with a market value of USD 245 million in the future, continues to lead the GI stents market. This dominance provides a solid foundation for innovation and specialization, allowing companies to capitalize on the region's advanced healthcare infrastructure and high demand for effective gastrointestinal treatments ((https://www.fortunebusinessinsights.com/gastrointestinal-stent-market-114932?utm_source=openai)).

Scope of the Report

SegmentSub-Segments
By Type

Self-expanding metal stents

Plastic stents

Covered stents

Uncovered stents

Others

By End-User

Hospitals

Ambulatory surgical centers

Specialty clinics

Others

By Material

Metal

Polymer

Composite

Others

By Application

Esophageal stenting

Colonic stenting

Biliary stenting

Others

By Distribution Channel

Direct sales

Distributors

Online sales

Others

By Region

Northeast

Midwest

South

West

By Patient Demographics

Age group (children, adults, elderly)

Gender

Comorbidities

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Food and Drug Administration, Centers for Medicare & Medicaid Services)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers and Hospitals

Medical Device Regulatory Consultants

Industry Associations (e.g., American Gastroenterological Association)

Health Insurance Companies

Players Mentioned in the Report:

Boston Scientific Corporation

Medtronic plc

Cook Medical

Abbott Laboratories

B. Braun Melsungen AG

Olympus Corporation

ConMed Corporation

Merit Medical Systems, Inc.

EndoChoice, Inc.

Stryker Corporation

C. R. Bard, Inc.

Halyard Health, Inc.

Ethicon, Inc.

Terumo Corporation

Medline Industries, Inc.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. USA Gastrointestinal GI Stents Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 USA Gastrointestinal GI Stents Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. USA Gastrointestinal GI Stents Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of gastrointestinal diseases
3.1.2 Advancements in stent technology
3.1.3 Rising geriatric population
3.1.4 Growing demand for minimally invasive procedures

3.2 Market Challenges

3.2.1 High cost of stent procedures
3.2.2 Complications associated with stent placement
3.2.3 Stringent regulatory requirements
3.2.4 Limited reimbursement policies

3.3 Market Opportunities

3.3.1 Expansion of healthcare infrastructure
3.3.2 Increasing investment in R&D
3.3.3 Rising awareness about gastrointestinal health
3.3.4 Potential for international market expansion

3.4 Market Trends

3.4.1 Shift towards biodegradable stents
3.4.2 Integration of digital health technologies
3.4.3 Personalized medicine approaches
3.4.4 Collaborations between healthcare providers and manufacturers

3.5 Government Regulation

3.5.1 FDA approval processes for new stent technologies
3.5.2 Guidelines for stent usage in clinical practice
3.5.3 Reporting requirements for adverse events
3.5.4 Reimbursement policies for GI stent procedures

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. USA Gastrointestinal GI Stents Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. USA Gastrointestinal GI Stents Market Segmentation

8.1 By Type

8.1.1 Self-expanding metal stents
8.1.2 Plastic stents
8.1.3 Covered stents
8.1.4 Uncovered stents
8.1.5 Others

8.2 By End-User

8.2.1 Hospitals
8.2.2 Ambulatory surgical centers
8.2.3 Specialty clinics
8.2.4 Others

8.3 By Material

8.3.1 Metal
8.3.2 Polymer
8.3.3 Composite
8.3.4 Others

8.4 By Application

8.4.1 Esophageal stenting
8.4.2 Colonic stenting
8.4.3 Biliary stenting
8.4.4 Others

8.5 By Distribution Channel

8.5.1 Direct sales
8.5.2 Distributors
8.5.3 Online sales
8.5.4 Others

8.6 By Region

8.6.1 Northeast
8.6.2 Midwest
8.6.3 South
8.6.4 West

8.7 By Patient Demographics

8.7.1 Age group (children, adults, elderly)
8.7.2 Gender
8.7.3 Comorbidities
8.7.4 Others

9. USA Gastrointestinal GI Stents Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Product Innovation Rate
9.2.7 Distribution Efficiency
9.2.8 Pricing Strategy
9.2.9 Customer Satisfaction Score
9.2.10 Sales Conversion Rate

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Boston Scientific Corporation
9.5.2 Medtronic plc
9.5.3 Cook Medical
9.5.4 Abbott Laboratories
9.5.5 B. Braun Melsungen AG
9.5.6 Olympus Corporation
9.5.7 ConMed Corporation
9.5.8 Merit Medical Systems, Inc.
9.5.9 EndoChoice, Inc.
9.5.10 Stryker Corporation
9.5.11 C. R. Bard, Inc.
9.5.12 Halyard Health, Inc.
9.5.13 Ethicon, Inc.
9.5.14 Terumo Corporation
9.5.15 Medline Industries, Inc.

10. USA Gastrointestinal GI Stents Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget allocation for GI stents
10.1.2 Decision-making processes
10.1.3 Supplier selection criteria
10.1.4 Contract management practices

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in healthcare facilities
10.2.2 Spending on medical equipment
10.2.3 Budgeting for GI stent procurement
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges faced by hospitals
10.3.2 Issues in ambulatory surgical centers
10.3.3 Concerns of specialty clinics
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Training requirements for staff
10.4.2 Infrastructure readiness
10.4.3 Patient acceptance levels
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of ROI
10.5.2 Case studies of successful implementations
10.5.3 Opportunities for expanding use cases
10.5.4 Others

11. USA Gastrointestinal GI Stents Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market gaps identification

1.2 Business model development


2. Marketing and Positioning Recommendations

2.1 Branding strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban retail vs rural NGO tie-ups


4. Channel & Pricing Gaps

4.1 Underserved routes

4.2 Pricing bands


5. Unmet Demand & Latent Needs

5.1 Category gaps

5.2 Consumer segments


6. Customer Relationship

6.1 Loyalty programs

6.2 After-sales service


7. Value Proposition

7.1 Sustainability

7.2 Integrated supply chains


8. Key Activities

8.1 Regulatory compliance

8.2 Branding

8.3 Distribution setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product mix
9.1.2 Pricing band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target countries
9.2.2 Compliance roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven analysis

13.2 Long-term sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone tracking
15.2.2 Activity scheduling

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from healthcare organizations and market research firms
  • Review of published articles in medical journals focusing on gastrointestinal stents
  • Examination of regulatory documents from the FDA regarding stent approvals and guidelines

Primary Research

  • Interviews with gastroenterologists and surgeons specializing in GI procedures
  • Surveys conducted with hospital procurement departments regarding stent purchasing
  • Field interviews with medical device distributors and suppliers in the GI sector

Validation & Triangulation

  • Cross-validation of findings through multiple expert interviews and focus groups
  • Triangulation of data from clinical studies, market reports, and expert opinions
  • Sanity checks through feedback from a panel of industry experts and stakeholders

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total market size based on national healthcare expenditure on GI treatments
  • Segmentation of market by stent type, application, and geographical distribution
  • Incorporation of trends in minimally invasive procedures and patient demographics

Bottom-up Modeling

  • Collection of sales data from leading manufacturers of GI stents
  • Estimation of market share based on unit sales and revenue figures
  • Volume x average selling price calculations for different stent categories

Forecasting & Scenario Analysis

  • Multi-variable forecasting using historical growth rates and emerging market trends
  • Scenario analysis based on potential regulatory changes and technological advancements
  • Development of baseline, optimistic, and pessimistic market projections through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Gastroenterology Clinics100Gastroenterologists, Clinic Managers
Hospitals with GI Departments150Surgeons, Procurement Officers
Medical Device Distributors80Sales Representatives, Product Managers
Patient Advocacy Groups60Patient Coordinators, Health Educators
Regulatory Bodies40Regulatory Affairs Specialists, Compliance Officers

Frequently Asked Questions

What is the current value of the USA Gastrointestinal GI Stents Market?

The USA Gastrointestinal GI Stents Market is valued at approximately USD 0.6 billion, reflecting a five-year historical analysis. This valuation is influenced by the rising prevalence of gastrointestinal cancers and lifestyle-related digestive disorders.

What factors are driving the growth of the GI stents market in the USA?

Who are the key players in the USA Gastrointestinal GI Stents Market?

What types of stents are available in the USA GI stents market?

Other Regional/Country Reports

Indonesia Gastrointestinal GI Stents Market

Malaysia Gastrointestinal GI Stents Market

KSA Gastrointestinal GI Stents Market

APAC Gastrointestinal GI Stents Market

SEA Gastrointestinal GI Stents Market

Vietnam Gastrointestinal GI Stents Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022